Supriya Lifescience Ltd - 543434 - Submission Of Outcome Of Voting Results & Consolidated Scrutinizers Report Of 14Th Annual General Meeting Held On September 16, 2022.
Please find enclosed herewith Outcome of voting results of 14th Annual General Meeting held on September 16, 2022 as per Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Consolidated Scrutinizer''s Report (Remote E-voting Result and E-voting during the AGM). Supriya Lifescience Ltd - 543434 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Please find enclosed herewith Scrutinizer''''s Report (Remote E-voting Result and E-voting during the AGM) of 14th Annual General Meeting held on September 16, 2022. Supriya Lifescience Ltd - 543434 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to Regulation 30 read with Para A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith gist of proceedings of the 14th Annual General Meeting held on Friday, September 16, 2022. Supriya Lifescience Ltd - 543434 - Additional Information With Respect To The Notice Dated August 12, 2022 For The 14Th Annual General Meeting Of The Company Scheduled To Be Held On Friday, September 16, 2022 ('AGM Notice')
With reference to the captioned matter, the Company is furnishing following additional information in relation to Items Nos. 4 set out in the AGM Notice, for the kind attention of the members of the Company: Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited ('Company') will be interacting with Analyst/Institutional Investors on September 1, 2022 via in person meeting. This is to further inform that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company's website www.supriyalifescience.com for your information and for the information of your members and the public at large. This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Note: The above date is subject to change. Change may happen due to exigencies on the part of Company or Analyst/Investor/Fund. Request you to kindly take the same on record. Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited ('Company') will be interacting with Analyst/Institutional Investors on August 25, 2022 via video conference. This is to further inform that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company's website www.supriyalifescience.com for your information and for the information of your members and the public at large. This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Note: The above date is subject to change. Change may happen due to exigencies on the part of Company or Analyst/Investor/Fund. Request you to kindly take the same on record. Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In terms of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of the advertisement relating to the 14th Annual General Meeting of the Company to be held on Friday, September 16, 2022 through Video Conference ('VC') / Other Audio-Visual Means (OAVM') in the following newspapers: i. Financial Express (English Language) ii. Loksatta (Marathi Language) Kindly take the above said information on your records. Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited ('Company') will be interacting with Analyst/Institutional Investors on August 24, 2022 via video conference. This is to further inform that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company's website www.supriyalifescience.com for your information and for the information of your members and the public at large. This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Note: The above date is subject to change. Change may happen due to exigencies on the part of Company or Analyst/Investor/Fund. Request you to kindly take the same on record. Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby enclose the transcript of the Earnings call held on Tuesday, August 16, 2022 at 3.00 P.M. IST to discuss operational and financial performance of the Company for the quarter ended June 30, 2022 (Q1 of FY 2022-23). This is for your information and records. Supriya Lifescience Ltd - 543434 - Intimation Of Record Date And Book Closures Date For The Purpose Of Dividend & Annual General Meeting
Pursuant to Section 91 and other applicable provisions, if any of the Companies Act, 2013 and Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Register of Members and Share Transfer Books of the Company will remain closed from Saturday September 3, 2022 to Friday, September 16, 2022 (both days inclusive) purpose of Dividend and AGM. The Company has fixed Friday, September 2, 2022 as the 'Record Date' for determining entitlement of Members to final dividend for the financial year ended March 31, 2022, if approved at the AGM. Kindly take the above said information on your records.